Titre :

Methods for the analysis and treatment of cost data by micro- and gross-costing approaches

Auteur(s) :

Morelle, M. [Auteur]
Université Claude Bernard Lyon 1 [UCBL]
Plantier, M. [Auteur]
Université Claude Bernard Lyon 1 [UCBL]
Dervaux, Benoit [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Pages, A. [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Denies, Fanette [Auteur]
Université Claude Bernard Lyon 1 [UCBL]
Havet, N. [Auteur]
Université Claude Bernard Lyon 1 [UCBL]
Perrier, L. [Auteur]
Université Claude Bernard Lyon 1 [UCBL]
Plantier, M. [Auteur]

Titre de la revue :

Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique

Nom court de la revue :

Rev Epidemiol Sante Publique

Numéro :

66

Pagination :

S101-S118

Date de publication :

2018-03

ISSN :

0398-7620

Mot(s)-clé(s) en anglais :

Production
Technology
Hospital
Guidelines
Evaluation
Cost

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

This work addresses the analysis of individual cost data in the setting of interventional or observational studies using statistical analysis software once the costs per patient have been estimated. It is in fact necessary ...
Lire la suite >This work addresses the analysis of individual cost data in the setting of interventional or observational studies using statistical analysis software once the costs per patient have been estimated. It is in fact necessary to be able to present and describe data in an appropriate manner in each of the studied health strategies and to test whether the difference in costs observed between treatment groups is due to chance or not. Furthermore, cost analysis differs from conventional statistical analysis in that cost data have a certain number of specific properties, including their use by health decision-makers. This work also addresses the difficulties that generally arise in regard to the distribution of cost; it explains why the mathematical average constitutes the only relevant measure for economists; and it outlines which analyses are required for inter-strategy cost comparisons. It also covers the issue of missing or censored data, features that are inherent to information collected regarding costs and to sensitivity analyses.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

CHU Lille
Université de Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Date de dépôt :

2019-12-09T18:18:04Z
2024-05-24T11:43:43Z